Cladribine tablets in people with relapsing multiple sclerosis A real-world multicentric study from southeast European MS centers /
Cladribine is an oral disease-modifying drug authorized by the European Medicine Agency for the treatment of highly active relapsing multiple sclerosis (MS).To provide real-world evidence of cladribine's effectiveness and safety in people with MS (pwMS).A retrospective observational multi-cente...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2023
|
| Sorozat: | JOURNAL OF NEUROIMMUNOLOGY
382 |
| Tárgyszavak: | |
| doi: | 10.1016/j.jneuroim.2023.578164 |
| mtmt: | 34090990 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/28099 |